Latest Financials News

Alterity Therapeutics is poised to release topline data from its pivotal ATH434-201 Phase 2 trial in early-stage Multiple System Atrophy by February 2025, while managing a cash balance of A$4.54 million amid ongoing research expenses.

Pacgold Limited reports promising high-grade gold anomalies from a major aircore drilling campaign at its Alice River Gold Project, alongside strategic board appointments and a successful Share Purchase Plan to fuel further exploration.

Gathid Ltd reports a strong quarter with a 92% year-on-year increase in Annual Recurring Revenue, new customer wins, and industry recognition, despite ongoing challenges in finalising the sale of its physical security business.

Trinex Minerals has made significant progress at its Dudley Lithium Project on Kangaroo Island, securing key landowner agreements and completing a large soil sampling program that revealed multiple lithium anomalies. The company plans to commence drilling in March 2025, marking a pivotal step in its exploration strategy.

Meeka Metals has responded to an ASX query regarding the timing and nature of its recent cleansing notice, confirming that the drilling results reinforce existing mineral resources without revealing new discoveries.

Monadelphous Group Limited signals a stronger-than-expected half-year profit, driven by improved operating margins and favourable non-operating items.

Metrics Master Income Trust has announced an estimated unfranked dividend of AUD 0.0137 per unit, payable in February 2025, alongside a full Dividend Reinvestment Plan option.

Metrics Real Estate Multi-Strategy Fund has announced an estimated ordinary dividend of AUD 0.0096 per security, with key dates set for late January and early February 2025. The dividend is unfranked and relates to the financial period ending January 31, 2025.

Clime Investment Management has reported a return to profitability in the December half, proposing an interim dividend and unveiling strategic initiatives to drive future growth.

VanEck Investments Limited has outlined the dividend timetable for its suite of Australian and global bond ETFs, providing investors with critical dates for dividend entitlements and reinvestment options.

Income Asset Management delivered steady revenue of $4.0 million in Q2 FY2025 alongside significant growth in funds under administration and client accounts, while retiring $10 million in debt to reduce interest costs.

BOD Science has executed an asset sale deed transferring critical intellectual property rights to Optimus Salvus, marking a pivotal step in its Deed of Company Arrangement process.